Trials / Conditions / Metastatic Digestive System Neuroendocrine Neoplasm
Metastatic Digestive System Neuroendocrine Neoplasm
4 registered clinical trials studyying Metastatic Digestive System Neuroendocrine Neoplasm — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreati NCT06016855 | Vanderbilt-Ingram Cancer Center | Phase 4 |
| Active Not Recruiting | Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 NCT04234568 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine T NCT03891784 | University of Washington | Phase 2 |
| Active Not Recruiting | Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors NCT03375320 | National Cancer Institute (NCI) | Phase 3 |